Genome organization and reverse genetic analysis of a type I feline coronavirus

Journal of Virology

Volumn 82, Issue 4, 2008, Pages 1851-1859

  Tekes, Gergely ^a   Hofmann Lehmann, Regina ^b   Stallkamp, Iris ^a   Thiel, Volker ^c   Thiel, Heinz Jürgen ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; LUCIFERASE;

ACCESSORY 3ABC GENE; ARTICLE; CORONAVIRUS; DENDRITIC CELL; GENE; GENETIC ANALYSIS; MOLECULAR BIOLOGY; MOLECULAR CLONING; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RENILLA; SERODIAGNOSIS; VACCINIA VIRUS; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD14; BASE SEQUENCE; CATS; CLONING, MOLECULAR; CORONAVIRUS, FELINE; DENDRITIC CELLS; DNA, COMPLEMENTARY; GENE ORDER; GENES, REPORTER; GENOME, VIRAL; GREEN FLUORESCENT PROTEINS; LUCIFERASES, RENILLA; MOLECULAR SEQUENCE DATA; MONOCYTES; SEQUENCE ANALYSIS, DNA; SEROTYPING;

FELIDAE; FELINE CORONAVIRUS; RENILLA LUCIFERASE; VACCINIA VIRUS;

EID: 38849113923     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02339-07     Document Type: Article

References (60)

1. Addie, D. D., and O. Jarrett. 2001. Use of a reverse-transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by healthy cats. Vet. Rec. 148:649-653.
2. Addie, D. D., I. A. Schaap, L. Nicolson, and O. Jarrett. 2003. Persistence and transmission of natural type I feline coronavirus infection. J. Gen. Virol. 84:2735-2744.
3. Berg, A. L., K. Ekman, S. Belak, and M. Berg. 2005. Cellular composition and interferon-gamma expression of the local inflammatory response in feline infectious peritonitis (FIP). Vet. Microbiol. 111:15-23.
4. Black, J. W. 1980. Recovery and in vitro cultivation of a coronavirus from laboratory-induced cases of feline infectious peritonitis (FIP). Vet. Med. Small Anim. Clin. 75:811-814.
5. Casais, R., V. Thiel, S. G. Siddell, D. Cavanagh, and P. Britton. 2001. Reverse genetics system for the avian coronavirus infectious bronchitis virus. J. Virol. 75:12359-12369.
6. Casais, R., M. Davies, D. Cavanagh, and P. Britton. 2005. Gene 5 of the avian coronavirus infectious bronchitis virus is not essential for replication. J. Virol. 79:8065-8078.
7. Cervantes-Barragan, L., R. Zust, F. Weber, M. Spiegel, K. S. Lang, S. Akira, V. Thiel, and B. Ludewig. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109:1131-1137.
8. Coley, S. E., E. Lavi, S. G. Sawicki, L. Fu, B. Schelle, N. Karl, S. G. Siddell, and V. Thiel. 2005. Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J. Virol. 79:3097-3106.
9. Curtis, K. M., B. Yount, and R. S. Baric. 2002. Heterologous gene expression from transmissible gastroenteritis virus replicon particles. J. Virol. 76:1422-1434.
10. de Haan, C. A., P. S. Masters, X. Shen, S. Weiss, and P. J. Rottier. 2002. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology 296:177-189.
11. de Haan, C. A., L. van Genne, J. N. Stoop, H. Volders, and P. J. Rottier. 2003. Coronaviruses as vectors: position dependence of foreign gene expression. J. Virol. 77:11312-11323.
12. de Haan, C. A., B. J. Haijema, D. Boss, F. W. Heuts, and P. J. Rottier. 2005. Coronaviruses as vectors: stability of foreign gene expression. J. Virol. 79:12742-12751.
13. Dewerchin, H. L., E. Cornelissen, and H. J. Nauwynck. 2005. Replication of feline coronaviruses in peripheral blood monocytes. Arch. Virol. 150:2483-2500.
14. Dye, C., and S. G. Siddell. 2005. Genomic RNA sequence of Feline coronavirus strain FIPV WSU-79/1146. J. Gen. Virol. 86:2249-2253.
15. Dye, C., N. Temperton, and S. G. Siddell. 2007. Type I feline coronavirus spike glycoprotein fails to recognize aminopeptidase N as a functional receptor on feline cell lines. J. Gen. Virol. 88:1753-1760.
16. Fischer, F., C. F. Stegen, C. A. Koetzner, and P. S. Masters. 1998. Construction of a mouse hepatitis virus recombinant expressing a foreign gene. Adv. Exp. Med. Biol. 440:291-295.
17. Foley, J. E., A. Poland, J. Carlson, and N. C. Pedersen. 1997. Patterns of feline coronavirus infection and fecal shedding from cats in multiple-cat environments. J. Am. Vet. Med. Assoc. 210:1307-1312.
18. Gonzalez, J. M., P. Gomez-Puertas, D. Cavanagh, A. E. Gorbalenya, and L. Enjuanes. 2003. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch. Virol. 148:2207-2235.
19. Gorbalenya, A. E., L. Enjuanes, J. Ziebuhr, and E. J. Snijder. 2006. Nidovirales: evolving the largest RNA virus genome. Virus Res. 117:17-37.
20. Gunn-Moore, D. A., T. J. Gruffydd-Jones, and D. A. Harbour. 1998. Detection of feline coronaviruses by culture and reverse transcriptase- polymerase chain reaction of blood samples from healthy cats and cats with clinical feline infectious peritonitis. Vet. Microbiol. 62:193-205.
21. Haijema, B. J., H. Volders, and P. J. Rottier. 2003. Switching species tropism: an effective way to manipulate the feline coronavirus genome. J. Virol. 77:4528-4538.
22. Haijema, B. J., H. Volders, and P. J. Rottier. 2004. Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J. Virol. 78:3863-3871.
23. Hegyi, A., and A. F. Kolb. 1998. Characterization of determinants involved in the feline infectious peritonitis virus receptor function of feline aminopeptidase N. J. Gen. Virol. 79:1387-1391.
24. Herrewegh, A. A., R. J. de Groot, A. Cepica, H. F. Egberink, M. C. Horzinek, and P. J. Rottier. 1995. Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR. J. Clin. Microbiol. 33:684-689.
25. Herrewegh, A. A., H. Vennema, M. C. Horzinek, P. J. Rottier, and R. J. de Groot. 1995. The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology 212:622-631.
26. Herrewegh, A. A., M. Mahler, H. J. Hedrich, B. L. Haagmans, H. F. Egberink, M. C. Horzinek, P. J. Rottier, and R. J. de Groot 1997. Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology 234:349-363.
27. Herrewegh, A. A., I. Smeenk, M. C. Horzinek, P. J. Rottier, and R. J. de Groot. 1998. Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J. Virol. 72:4508-4514.
28. Hertzig, T., E. Scandella, B. Schelle, J. Ziebuhr, S. G. Siddell, B. Ludewig, and V. Thiel. 2004. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. J. Gen. Virol. 85:1717-1725.
29. Hohdatsu, T., S. Okada, and H. Koyama. 1991. Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronaviruses. Arch. Virol. 117:85-95.
30. Hohdatsu, T., T. Sasamoto, S. Okada, and H. Koyama. 1991. Antigenic analysis of feline coronaviruses with monoclonal antibodies (MAbs): preparation of MAbs which discriminate between FIPV strain 79-1146 and FECV strain 79-1683. Vet. Microbiol. 28:13-24.
31. Hohdatsu, T., S. Okada, Y. Ishizuka, H. Yamada, and H. Koyama. 1992. The prevalence of types I and II feline coronavirus infections in cats. J. Vet. Med. Sci. 54:557-562.
32. Hohdatsu, T., Y. Izumiya, Y. Yokoyama, K. Kida, and H. Koyama. 1998. Differences in virus receptor for type I and type II feline infectious peritonitis virus. Arch. Virol. 143:839-850.
33. Kennedy, M., N. Boedeker, P. Gibbs, and S. Kania. 2001. Deletions in the 7a ORF of feline coronavirus associated with an epidemic of feline infectious peritonitis. Vet. Microbiol. 81:227-234.
34. Kennedy, M., S. Citino, A. H. McNabb, A. S. Moffatt, K. Gertz, and S. Kania. 2002. Detection of feline coronavirus in captive Felidae in the USA. J. Vet. Diagn. Investig. 14:520-522.
35. Kipar, A., S. Bellmann, J. Kremendahl, K. Kohler, and M. Reinacher. 1998. Cellular composition, coronavirus antigen expression and production of specific antibodies in lesions in feline infectious peritonitis. Vet. Immunol. Immunopathol. 65:243-257.
36. Kipar, A., S. Bellmann, D. A. Gunn-Moore, W. Leukert, K. Kohler, S. Menger, and M. Reinacher. 1999. Histopathological alterations of lymphatic tissues in cats without feline infectious peritonitis after long-term exposure to FIP virus. Vet. Microbiol. 69:131-137.
37. Kipar, A., H. May, S. Menger, M. Weber, W. Leukert, and M. Reinacher. 2005. Morphologic features and development of granulomatous vasculitis in feline infectious peritonitis. Vet. Pathol. 42:321-330.
38. Kummrow, M., M. L. Meli, M. Haessig, E. Goenczi, A. Poland, N. C. Pedersen, R. Hofmann-Lehmann, and H. Lutz. 2005. Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin. Diagn. Lab. Immunol. 12:1209-1215.
39. Meli, M., A. Kipar, C. Muller, K. Jenal, E. Gonczi, N. Borel, D. Gunn-Moore, S. Chalmers, F. Lin, M. Reinacher, and H. Lutz. 2004. High viral loads despite absence of clinical and pathological findings in cats experimentally infected with feline coronavirus (FCoV) type I and in naturally FCoV-infected cats. J. Feline Med. Surg. 6:69-81.
40. Ortego, J., I. Sola, F. Almazan, J. E. Ceriani, C. Riquelme, M. Balasch, J. Plana, and L. Enjuanes. 2003. Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence. Virology 308:13-22.
41. Paltrinieri, S., V. Grieco, S. Comazzi, and M. Cammarata Parodi. 2001. Laboratory profiles in cats with different pathological and immunohistochemical findings due to feline infectious peritonitis (FIP). J. Feline Med. Surg. 3:149-159.
42. Pedersen, N. C., and J. W. Black. 1983. Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am. J. Vet. Res. 44:229-234.
43. Pedersen, N. C., J. W. Black, J. F. Boyle, J. F. Evermann, A. J. McKeirnan, and R. L. Ott. 1984. Pathogenic differences between various feline coronavirus isolates, p. 356-380. In P. J. Rottier, B. A. M. Zeijst, W. J. M. Spaan, and M. C. Horzinek (ed.), Molecular biology and pathogenesis of coronaviruses. Plenum, New York, NY.
44. Rottier, P. J., K. Nakamura, P. Schellen, H. Volders, and B. J. Haijema. 2005. Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J. Virol. 79:14122-14130.
45. Sarma, J. D., E. Scheen, S. H. Seo, M. Koval, and S. R. Weiss. 2002. Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system. J. Neurovirol. 8:381-391.
46. Schwarz, B., E. Routledge, and S. G. Siddell. 1990. Murine coronavirus nonstructural protein ns2 is not essential for virus replication in transformed cells. J. Virol. 64:4784-4791.
47. Sola, I., S. Alonso, S. Zuniga, M. Balasch, J. Plana-Duran, and L. Enjuanes. 2003. Engineering the transmissible gastroenteritis virus genome as an expression vector inducing lactogenic immunity. J. Virol. 77:4357-4369.
48. Sperry, S. M., L. Kazi, R. L. Graham, R. S. Baric, S. R. Weiss, and M. R. Denison. 2005. Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice. J. Virol. 79:3391-3400.
49. Sprague, W. S., M. Pope, and E. A. Hoover. 2005. Culture and comparison of feline myeloid dendritic cells vs macrophages. J. Comp. Pathol. 133:136-145.
50. Stoddart, C. A., and F. W. Scott. 1988. Isolation and identification of feline peritoneal macrophages for in vitro studies of coronavirus-macrophage interactions. J. Leukoc. Biol. 44:319-328.
51. Thiel, V., J. Herold, B. Schelle, and S. G. Siddell. 2001. Viral replicase gene products suffice for coronavirus discontinuous transcription. J. Virol. 75:6676-6681.
52. Thiel, V., J. Herold, B. Schelle, and S. G. Siddell. 2001. Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J. Gen. Virol. 82:1273-1281.
53. Tresnan, D. B., R. Levis, and K. V. Holmes. 1996. Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J. Virol. 70:8669-8674.
54. Vennema, H., A. Poland, J. Foley, and N. C. Pedersen. 1998. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 243:150-157.
55. Vennema, H. 1999. Genetic drift and genetic shift during feline coronavirus evolution. Vet. Microbiol. 69:139-141.
56. Ward, J. M. 1970. Morphogenesis of a virus in cats with experimental feline infectious peritonitis. Virology 41:191-194.
57. Wentworth, D. E., and K. V. Holmes. 2001. Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation. J. Virol. 75:9741-9752.
58. Youn, S., J. L. Leibowitz, and E. W. Collisson. 2005. In vitro assembled, recombinant infectious bronchitis viruses demonstrate that the 5a open reading frame is not essential for replication. Virology 332:206-215.
59. Yount, B., M. R. Denison, S. R. Weiss, and R. S. Baric. 2002. Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J. Virol. 76:11065-11078.
60. Zust, R., L. Cervantes-Barragan, T. Kuri, G. Blakqori, F. Weber, B. Ludewig, and V. Thiel. 2007. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog. 3:e109.